By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Abbott Laboratories 

Department 383 AP6D
One Hundred Abbott Park Road
Abbott Park  Illinois  60064-3500  U.S.A.
Phone: 847-937-6100 Fax: 847-937-1511


SEARCH JOBS

Abbott has facilities in more than 40 countries and markets its products in more than 130 countries. More than 60,000 Abbott employees around the world have devoted their careers to advancing the practice of health care. The largest concentration of Abbott employees is in Lake County, Ill., home to both corporate headquarters at Abbott Park and the company's principal manufacturing location at North Chicago. Still, less than one-third of all Abbott employees are located in Illinois. The majority of our employees are spread across the United States and around the world.

Abbott is building a global portfolio around two key groups - pharmaceuticals and medical products - that form a strategically cohesive business mix.

Our Pharmaceutical Products Group strives to consistently discover, develop and market breakthrough drugs that improve patient health, especially in areas of unmet medical need. The group's primary focus is on translating innovative science into effective medicine and spans several areas, including the Pharmaceutical Products Division, the Nutritionals Division and Abbott International, as well as TAP Pharmaceuticals Inc., Abbott's joint venture with Takeda Chemical Industries, Ltd.

Our Medical Products Group is building leading businesses in hospital based medicines and devices, diagnostic tests and instruments, and nutritionals for adults and children, while identifying ways to promote health through the linkage of drugs, devices, diagnostics and nutritional products.

There's a world of inspiration that you can only get from being a part of the Abbott team. That's because we are made up of people who are passionate about life, health care and the contributions they can make.

For over a century, innovation and success in the areas of pharmaceuticals, nutritionals and diagnostics has enabled Abbott to provide total, integrated solutions for some of the world's most prevalent medical conditions, including: AIDS, cancer and diabetes.

Abbott technologies span the health care spectrum and play a key role in the way people get well and stay healthy. And with $22 billion in sales in more than 130 countries, we don't just see a better world - we're positioned to make it happen.


YEAR FOUNDED:

1888

LEADERSHIP:

Founder: Wallace Calvin Abbott

CEO: Miles White

CFO: Brain Yoor

JOBS:

Please click here for Abbott job opportunities.

PRODUCTS:

All Products

FOLLOW ABBOTT:



Key Statistics


Email: abcjobs@abbott.com
Ownership: Public

Web Site: Abbott
Employees: 54,000
Symbol: ABT
 





Collaborations

Celera Diagnostics  Long-term strategic alliance to develop, manufacture and market a broad range of in vitro molecular diagnostic products for disease detection, disease progression monitoring and therapy selection.

Genetronics, Inc.  On November 26, 1997, Genetronics announced a supply agreement with Abbott Laboratories allowing Genetronics to purchase the approved anti-cancer drug bleomycin for use with Genetronics MedPulser┬« drug delivery system in treatment of cancer.

Metabolex, Inc. 

Celera Corporation  Broad program to discover, develop and commercialize therapies for the treatment of cancer, including therapeutic antibodies and small molecules.

Rosetta Inpharmatics, Inc.  Investigation on molecular basis of hepatoxicity

Medarex, Inc. 

MedImmune 





Company News
Abbott (ABT) Wins FDA OK for the FreeStyle Libre Pro System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use With Their Patients 9/28/2016 7:53:40 AM
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic 9/22/2016 7:30:57 AM
Abbott (ABT) Hosts Conference Call for Third-Quarter Earnings 9/21/2016 8:40:40 AM
How Abbott (ABT)'s Eye Deal With Johnson & Johnson (JNJ) Isn't About Alere (ALR) 9/20/2016 7:04:12 AM
M&A Bonanza Continues as Johnson & Johnson (JNJ) Pays $4.325 Billion for Abbott (ABT)'s Eye Surgery Biz 9/16/2016 2:49:51 PM
Abbott (ABT) Declares 371st Consecutive Quarterly Dividend 9/15/2016 10:29:46 AM
Abbott (ABT) Named Industry Leader For Responsible And Sustainable Business For Four Consecutive Years On The Dow Jones Sustainability Index (DJSI) 9/9/2016 9:31:43 AM
Alere (ALR) Lawsuit Accuses Abbott (ABT) of 'Buyer's Remorse' in Proposed Merger 9/1/2016 6:16:08 AM
Alere (ALR) Drags Abbott (ABT) to Court to Force Completion of $5.8 Billion Deal 8/26/2016 10:15:30 AM
Abbott (ABT) To Present At Wells Fargo Healthcare Conference 8/24/2016 10:52:19 AM
12345678910...
//-->